SAFETY AND EFFICACY OF CO-ADMINISTERED DIETHYLCARBAMZINE, ALBENDAZOLE AND IVERMECTION DURING MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS IN HAITI

被引:0
|
作者
Dubray, Christine [1 ]
Sircar, Anita [1 ]
de Rochars, Madsen [2 ]
Bogus, Joshua [3 ]
Direny, Abdel [4 ]
Ernest, Jean [5 ]
Fayette, Carl [5 ]
O'Brian, Katiuscia [3 ]
Pavilus, Guy [5 ]
Sabin, Daniel [5 ]
Wiegand, Ryan [1 ]
Weil, Gary [3 ]
Lemoine, Jean [6 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
[2] Univ Florida, Gainesville, FL USA
[3] Washington Univ, St Louis, MO USA
[4] RTI Int, Washington, DC USA
[5] IMA World Hlth, Port Au Prince, Haiti
[6] Minist Publ Hlth & Populat, Port Au Prince, Haiti
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1
引用
收藏
页码:1 / 1
页数:1
相关论文
共 50 条
  • [41] Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole plus diethylcarbamazine plus ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial
    Tavul, Livingstone
    Laman, Moses
    Howard, Cade
    Kotty, Bethuel
    Samuel, Anna
    Bjerum, Catherine
    O'Brian, Kobie
    Kumai, Steven
    Amuga, Matthew
    Lorry, Lina
    Kerry, Zebedee
    Kualawi, Melvin
    Karl, Stephan
    Makita, Leo
    John, Lucy N.
    Bieb, Sibauk
    Wangi, James
    Weil, Gary J.
    Goss, Charles W.
    Tisch, Daniel J.
    Pomat, William
    King, Christopher L.
    Robinson, Leanne J.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2022, 16 (02):
  • [42] THE RELATIVE SAFETY OF A PROMISING TRIPLE DRUG MASS DRUG ADMINISTRATION REGIMEN VERSUS A TWO-DRUG REGIMEN FOR LYMPHATIC FILARIASIS ELIMINATION IN INDIA
    Purushothaman, Jambulingam
    Kuttiatt, Vijesh
    Swaminathan, Subramanian
    Kaliannagounder, Krishnamoorthy
    Adinarayanan, Srividya
    Weil, Gary
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 614 - 614
  • [43] Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India
    Babu, BV
    Rath, K
    Kerketta, AS
    Swain, BK
    Mishra, S
    Kar, SK
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2006, 100 (05) : 464 - 469
  • [44] Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Cote d'Ivoire
    Edi, Constant
    Bjerum, Catherine M.
    Ouattara, Allassane F.
    Chhonker, Yashpal S.
    Penali, Louis K.
    Meite, Aboulaye
    Koudou, Benjamin G.
    Weil, Gary J.
    King, Christopher L.
    Murry, Daryl J.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (05):
  • [45] Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis
    Jambulingam, Purushothaman
    Subramanian, Swaminathan
    Krishnamoorthy, Kaliannagounder
    Supali, Taniawati
    Fischer, Peter
    Dubray, Christine
    Fayette, Carl
    Lemoine, Jean Frantz
    Laman, Moses
    King, Christopher
    Samuela, Josaia
    Hardy, Myra
    Weil, Gary J.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2022, 106 (05): : 18 - 25
  • [46] IMPROVING COMMUNITY VOLUNTEER ENGAGEMENT AND IMPLEMENTATION OF MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS THROUGH MICROPLANNING: A CASE STUDY OF PORT-AU-PRINCE, HAITI
    Javel, Alain
    Fayette, Carl
    Monestime, Franck
    Knowles, Ellen
    Denis, Eurica
    Bennett, Cudjoe
    Lemoine, Jean-Frantz
    Brant, Tara
    Worrell, Caitlin
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 170 - 170
  • [47] The roles of stakeholder experience and organizational learning in declining mass drug administration coverage for lymphatic filariasis in Port-au-Prince, Haiti: A case study
    Wodnik, Breanna K.
    Louis, Didie Herold
    Joseph, Michel
    Wilkers, Lee T.
    Landskroener, Susan D.
    Desir, Luccene
    Lemoine, Jean Frantz
    Lavery, James V.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2020, 14 (05): : 1 - 18
  • [48] LESSONS FROM LYMPHATIC FILARIASIS TRANSMISSION INTERRUPTION IN HAITI: ARE FIVE ROUNDS OF ANNUAL MASS DRUG ADMINISTRATION (MDA) NECESSARY IN LOW-PREVALENCE SETTINGS?
    Monestime, Franck
    Fayette, Carl
    Javel, Alain
    Miller, Lior
    Craciunoiu, Sarah
    Desir, Luccene
    Direny, Abdel
    Hemme, Ryan R.
    Samuels, Jean-Aaron M.
    Streit, Thoma G.
    Worrel, Caitlin
    Won, Kim
    Lammie, Patrick
    Lemoine, Jean-Franz
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 155 - 156
  • [49] Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India
    Babu, B
    Kar, SK
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (06) : 702 - 709
  • [50] Long-term population migration: an important aspect to be considered during mass drug administration for elimination of lymphatic filariasis
    Sunish, IP
    Rajendran, R
    Mani, TR
    Gajanana, A
    Reuben, R
    Satyanarayana, K
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2003, 8 (04) : 316 - 321